[go: up one dir, main page]

AU2003205543A1 - Dry dispersions - Google Patents

Dry dispersions

Info

Publication number
AU2003205543A1
AU2003205543A1 AU2003205543A AU2003205543A AU2003205543A1 AU 2003205543 A1 AU2003205543 A1 AU 2003205543A1 AU 2003205543 A AU2003205543 A AU 2003205543A AU 2003205543 A AU2003205543 A AU 2003205543A AU 2003205543 A1 AU2003205543 A1 AU 2003205543A1
Authority
AU
Australia
Prior art keywords
dry dispersions
dispersions
dry
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2003205543A
Inventor
Anders Buur
Tue Hansen
Per Holm
Kirsten Schultz
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Veloxis Pharmaceuticals AS
Original Assignee
Lifecycle Pharma AS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lifecycle Pharma AS filed Critical Lifecycle Pharma AS
Publication of AU2003205543A1 publication Critical patent/AU2003205543A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605Excipients; Inactive ingredients
    • A61K9/1629Organic macromolecular compounds
    • A61K9/1652Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605Excipients; Inactive ingredients
    • A61K9/1617Organic compounds, e.g. phospholipids, fats
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1682Processes
    • A61K9/1694Processes resulting in granules or microspheres of the matrix type containing more than 5% of excipient
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605Excipients; Inactive ingredients
    • A61K9/1611Inorganic compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2072Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Medicinal Preparation (AREA)
AU2003205543A 2003-01-14 2003-01-14 Dry dispersions Abandoned AU2003205543A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/DK2003/000023 WO2004062643A1 (en) 2003-01-14 2003-01-14 Dry dispersions

Publications (1)

Publication Number Publication Date
AU2003205543A1 true AU2003205543A1 (en) 2004-08-10

Family

ID=32695525

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2003205543A Abandoned AU2003205543A1 (en) 2003-01-14 2003-01-14 Dry dispersions

Country Status (2)

Country Link
AU (1) AU2003205543A1 (en)
WO (1) WO2004062643A1 (en)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8025899B2 (en) 2003-08-28 2011-09-27 Abbott Laboratories Solid pharmaceutical dosage form
US8377952B2 (en) 2003-08-28 2013-02-19 Abbott Laboratories Solid pharmaceutical dosage formulation
US20050058673A1 (en) 2003-09-09 2005-03-17 3M Innovative Properties Company Antimicrobial compositions and methods
CN1976723B (en) 2004-04-30 2010-12-29 Bkg制药有限公司 Use of preparing medicine for treating or preventing infectious diseases
CN101175474B (en) 2005-03-10 2011-09-07 3M创新有限公司 Ways to reduce microbial contamination
JP2008537732A (en) 2005-03-10 2008-09-25 スリーエム イノベイティブ プロパティズ カンパニー Antimicrobial composition comprising an ester of hydroxycarboxylic acid
EP2067475A4 (en) 2006-09-26 2010-12-15 Astellas Pharma Inc Tacrolimus sustained-release preparation
WO2008084698A1 (en) 2006-12-28 2008-07-17 Astellas Pharma Inc. Tacrolimus sustained release pharmaceutical composition
MX2009007235A (en) 2007-01-05 2009-10-16 Bkg Pharma Aps Low-carbohydrate milk with original calcium.
EP2246349A1 (en) 2009-04-20 2010-11-03 BKG Pharma ApS Treatment of infectious diseases
EP2543364A1 (en) * 2010-10-14 2013-01-09 Deva Holding Anonim Sirketi Formulations of cetyl myristate and/or cetyl palmitate
EP2583673A1 (en) * 2010-10-14 2013-04-24 Deva Holding Anonim Sirketi Coating of cetyl myristate and/or cetyl palmitate particles
EP2471385A1 (en) * 2010-12-29 2012-07-04 Deva Holding Anonim Sirketi Cetyl myristate and/or cetyl palmitate suspension formulations
EP2471528A1 (en) * 2010-12-29 2012-07-04 Deva Holding Anonim Sirketi A preparation method for suspension of cetyl myristate and/or cetyl palmitate
EP2471386A1 (en) * 2010-12-29 2012-07-04 Deva Holding Anonim Sirketi Cetyl myristate and/or cetyl palmitate suspension formulations
EP2471387A1 (en) * 2010-12-29 2012-07-04 Deva Holding Anonim Sirketi Cetyl myristate and/or cetyl palmitate suspension formulations
EP2526936B1 (en) * 2011-05-23 2015-04-15 Deva Holding Anonim Sirketi Particle size distribution of cetyl myristate and/or cetyl palmitate
US20150136130A1 (en) 2012-02-29 2015-05-21 Pulmatrix, Inc. Inhalable dry powders
CN103099797A (en) * 2013-02-19 2013-05-15 青岛正大海尔制药有限公司 Propylene glycol mannate sulfate capsule and its preparation method

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0867666A (en) * 1994-08-29 1996-03-12 Lion Corp Carotenoid-containing powder formulation and method for producing the same
JP4027535B2 (en) * 1998-05-26 2007-12-26 エーザイ・アール・アンド・ディー・マネジメント株式会社 Powder containing fat-soluble drug
GB0008785D0 (en) * 2000-04-10 2000-05-31 Novartis Ag Organic compounds

Also Published As

Publication number Publication date
WO2004062643A1 (en) 2004-07-29

Similar Documents

Publication Publication Date Title
AU2003272930A1 (en) Footwere
AU2003902455A0 (en) Cadmas
AU2003205543A1 (en) Dry dispersions
AU2003274573A1 (en) Deburrer
AU2003300235A1 (en) Flooring
AU2003241210A1 (en) Videocomputer
AU2003901725A0 (en) Dryer
AU2004905232A0 (en) Dryer
AU2003901420A0 (en) Condition matching
AU2004901495A0 (en) Condition matching
AU2004901583A0 (en) Condition matching
AU2003100378A4 (en) Scootermansydney
AU2003100325A4 (en) Freez-A-Cube
AU2003100006A4 (en) Adcaster
AU2003100198A4 (en) Colourband Browbands
AU2003902356A0 (en) The patch
AU2004906412A0 (en) The Pochodyla plug
HK1092833A (en) Improved food-grade-lubricant
AU2004907250A0 (en) Cashramspam 5
AU2004901782A0 (en) Costmate 2
AU2003901840A0 (en) Elevation means
AU2003283123A1 (en) The medi-cam
AU2003900333A0 (en) The crab-grab
AU2003901925A0 (en) Spillwaysafe
AU2003900642A0 (en) Benchbath

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase